See full description
Walker et al (2014) Gp91ds-tat, a selective NADPH oxidase peptide inhibitor, increases blood nitric oxide bioavailability in hind limb ischemia and reperfusion. The FASEB J. 28(1)
Search our datasheets by catalogue number, peptide sequence or name.
Discover more about how we can support you and our products.
Find answers to common queries about our products and company.
Cambridge Research Biochemicals 17-18 Belasis Court, Belasis Hall Technology Park Billingham TS23 4AZ
t +44 01642 567 183